Opening Remarks, Presidential & Program Chair Welcome
9:00 AM - 10:15 AM
General Session 1
10:15 AM - 10:45 AM
Break
10:45 AM - 12:00 PM
Oral Abstract Session 1
10:45 AM - 11:00 AM
A Phase 2 Extension Trial of the Safety and Immunogenicity of Cytomegalovirus mRNA-1647 Vaccine Through 36 Months in Healthy Adults (#001)
Speaker:
Benjamin Lorenz (Moderna, Inc.)
11:00 AM - 11:15 AM
Predicting IVF Success: A Machine Learning Model Integrating Vaginal Inflammation and Microbiome Dynamics (#002)
Speaker:
Ofri Bar (Department of Obstetrics and Gynecology, Massachusetts General Hospital and Harvard Medical School. Dept. of Microbiology and Molecular Genetics, Faculty of Medicine, Hebrew University of Jerusalem)
11:15 AM - 11:30 AM
Prospective Cohort Study of the Association between Periconceptual Vaginal Washing and Miscarriage (#003)
Speaker:
R Mcclelland (University of Washington)
11:30 AM - 11:45 AM
Evaluating the Feasibility of Implementing an Intervention to Improve Vaccination Communication and Support Informed Decision Making in Pregnancy, a Multi-methods, Pre-post Study (#004)
Speaker:
Marcia Bruce (University of Calgary)
12:00 PM - 1:00 PM
Industry Sponsored Symposium 2
1:00 PM - 2:00 PM
Poster Session 1
1:00 PM - 2:00 PM
Economic Burden of Recurrent Vulvovaginal Candidiasis: Quantifying Healthcare Resource Utilization and Costs (#005)
Speaker:
Suvapun Bunniran (GSK)
1:00 PM - 2:00 PM
Development of Method and Performance for Determination of Bacterial Vaginosis from Vaginal Swabs Using a Novel Research-Use-Only Syndromic Molecular Panel Prototype (#006)
Speaker:
Devon Essick (bioMérieux)
1:00 PM - 2:00 PM
Hepatitis C (HCV) in Pregnancy Improving Screening and Connecting Patients to Treatment: A Quality Improvement (QI) Study (#007)
Speaker:
Mehgan Lazenby (University of Louisville)
1:00 PM - 2:00 PM
Deciphering Species-Specific Contributions of Sneathia to Adverse Gynecologic and Reproductive Outcomes Using Genomics and In Vitro 3D Modeling (#008)
Speaker:
Paweł łaniewski (University of Arizona)
1:00 PM - 2:00 PM
Impact of Preoperative Azithromycin on Postoperative Infectious Complications in Patients Undergoing Cesarean Delivery in the Setting of Intraamniotic Infection (#009)
Speaker:
Jaye Boissiere (Duke University School of Medicine)
1:00 PM - 2:00 PM
5-Nitroimidazole Drug Susceptibility among Trichomonas vaginalis Isolates in a Cohort of Pregnant South African Women (#010)
Speaker:
Keonte Graves (University of Alabama at Birmingham)
1:00 PM - 2:00 PM
A Meta-Analysis of Sofosbuvir-Based Regimens for Hepatitis C Virus Treatment in Pregnancy (#011)
Speaker:
Catherine Chappell (University of Pittsburgh)
1:00 PM - 2:00 PM
Critical Cargo: Comparing Outcomes in Sepsis-Associated Obstetrical Transport via Air and Ground (#012)
Speaker:
Michaela Kelly (University of Texas Health San Antonio)
1:00 PM - 2:00 PM
Comprehensive Addiction Care in Pregnancy Provides Opportunities to Improve Antepartum STI Screening Rates and Prevent Perinatal Infections (#013)
Speaker:
Lindsey Hastings (University of Alabama at Birmingham/Children's of Alabama)
1:00 PM - 2:00 PM
Group B Streptococcus Colonization Rate and Its Effects on Neonatal Outcome Among Mothers Under Maternity Package Deal Program in a Tertiary Hospital in Cebu City From January 2022 to January 2024 (#014)
Speaker:
Alyssa Marie Clemente (University of Cebu Medical Center)
1:00 PM - 2:00 PM
Let’s Talk HIV Prevention: In-Depth Interviews with Cisgender Women in Gynecology Clinics (#015)
Speaker:
Shika Marur (University of Michigan)
1:00 PM - 2:00 PM
Hepatitis C in Appalachia: Descriptive Analysis of Maternal Cardiac Disease (#016)
Speaker:
Shelley Stiltner (University of Tennessee Knoxville)
1:00 PM - 2:00 PM
LA Cervix Care: Improving Cervical Cancer Prevention in Louisiana (#017)
Speaker:
Rachel Thevenot (LSU Health Shreveport)
1:00 PM - 2:00 PM
Usability Evaluation of the simpli-COLLECT Urine Collection Kit (#018)
Speaker:
Mark Sasaki (Abbott)
2:00 PM - 3:15 PM
Oral Abstract Session 2
2:00 PM - 2:15 PM
Dysregulated Expression of Genes Encoding Virulence Factors among Metronidazole-Resistant and Sensitive Trichomonas vaginalis Isolates (#019)
Speaker:
Keonte Graves (University of Alabama at Birmingham)
2:15 PM - 2:30 PM
Self-administered Intravaginal Artesunate for Cervical Precancer Treatment Among Women in Kenya: Preliminary Results from a Phase I Clinical (#020)
Speaker:
Chemtai Mungo (University of North Carolina Chapel Hill)
2:30 PM - 2:45 PM
Vaginal Cytokines and Metabolite Concentrations in Asymptomatic and Symptomatic Bacterial Vaginosis (#021)
Speaker:
Golsa Yazdy (Johns Hopkins University)
2:45 PM - 3:00 PM
Behavioral Factors Associated with the Estimated Probability of Bacterial Vaginosis in Women: A Logistic Regression Analysis of Number of Sexual Partners and Condom Use (#022)
Speaker:
Rob Markowitz (Evvy)
3:00 PM - 3:15 PM
Genomic Diversity and Immune Profiling of Fannyhessea Reveals Insight into Potential Role in Cervical Carcinogenesis (#023)
Speaker:
Nicole Jimenez (University of Arizona)
3:15 PM - 5:00 PM
Break
5:00 PM - 6:30 PM
Welcome Reception
Friday, July 18, 2025
7:30 AM - 8:30 AM
Industry Sponsored Symposium 3
8:30 AM - 9:30 AM
General Session 2
9:30 AM - 10:30 AM
Oral Abstract Session 3
9:30 AM - 9:45 AM
Regulation of Group B Streptococcus vaginal colonization factors (#024)
Speaker:
Laura Cook (Binghamton University - State University of New York)
9:45 AM - 10:00 AM
Assessing inflammatory potential of a cohort of primary Group B Streptococcus clinical isolates. (#025)
Speaker:
Shelby Stringer (University of Tennessee Graduate School of Medicine)
10:00 AM - 10:15 AM
#GroupBStrep on TikTok: The Swab Goes Where? (#026)
Speaker:
Brooke Schroeder (Duke University School of Medicine)
10:15 AM - 10:30 AM
Perinatal Group B Streptococcal Disease After Updated Screening Recommendations – United States, 2020 – 2022 (#027)
Speaker:
Anuradha Devabhaktuni (Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA)
10:30 AM - 11:00 AM
Break
11:00 AM - 12:00 PM
Poster Session 2
11:00 AM - 12:00 PM
Maternal infectious morbidity in patients who undergo cesarean delivery complicated by intraamniotic infection (#028)
Speaker:
Ysaac Zegeye (Duke University School of Medicine)
11:00 AM - 12:00 PM
Stability of Dry Vaginal Swab Specimens for Testing on Alinity m HR HPV (#029)
Speaker:
Kevin Nelson (Abbott Laboratories)
11:00 AM - 12:00 PM
Gardnerella and Urinary Tract Infection in Mice and Women (#030)
Speaker:
Sonia N. Whang (Washington University in St. Louis)
11:00 AM - 12:00 PM
Clinically Recognized Congenital Cytomegalovirus Infection and the Risk of Neurodevelopmental Disorders (#031)
Speaker:
Yanmin Zhu (Brigham and Women's Hospital and Harvard Medical School)
11:00 AM - 12:00 PM
A Retrospective Review of Maternal Outcomes After Departmental Education on Early Recognition and Diagnostic Criteria for Sepsis and Septic Shock (#032)
Speaker:
Nathalie Chang (University Of Texas Health Science Center San Antonio)
11:00 AM - 12:00 PM
Maternal Characteristics and Outcomes in Pregnancies Complicated by Funisitis and Intraamniotic Infection Delivered via Cesarean Section (#033)
Speaker:
Jaye Boissiere (Duke University School of Medicine)
11:00 AM - 12:00 PM
Hepatitis C in Appalachia: Descriptive Analysis of Maternal Intravenous Drug Use (#034)
Speaker:
Shelley Stiltner (University of Tennessee Knoxville)
11:00 AM - 12:00 PM
Rebranded, not Reinvented; Utilizing New Criteria for Diagnosis of Intra-Amniotic Infection (#035)
Speaker:
Erik Holder (University of Texas Health Science Center at San Antonio)
11:00 AM - 12:00 PM
Modeling Papillomavirus and Bacterial Vaginosis Co-infection in Mice (#036)
Speaker:
Nicole Gilbert (Washington University School of Medicine)
11:00 AM - 12:00 PM
Association between Maternal Age and Chorioamnionitis among Adolescent and Young Women in North Dakota (#037)
Speaker:
Emma Weisner (University of North Dakota School of Medicine and Health Sciences)
11:00 AM - 12:00 PM
Effect of bacterial vaginosis treatment on cervical T cell and Langerhans cell concentrations (#038)
Speaker:
Michelle C. Sabo (University of Washington)
11:00 AM - 12:00 PM
Effect of Post-Operative Cephalexin and Metronidazole on Infectious Morbidity after Cesarean Delivery (#039)
Speaker:
Tyler Gresham (Emory University School of Medicine)
11:00 AM - 12:00 PM
Usability Evaluation of the simpli-COLLECT Vaginal Swab Collection Kit (#040)
Speaker:
Mark Sasaki (Abbott)
12:00 PM - 12:15 PM
Break
12:15 PM - 1:15 PM
Industry Sponsored Symposium 4
1:15 PM - 2:30 PM
Oral Abstract Session 4
1:15 PM - 1:30 PM
Postpartum Antibiotic Regimen and Risk of Postpartum Infections in Patients Undergoing Cesarean Delivery in the Setting of Intraamniotic Infection (#041)
Speaker:
Jaye Boissiere (Duke University School of Medicine)
1:30 PM - 1:45 PM
Preoperative Azithromycin Improves Neonatal Outcomes in Infants Delivered by Cesarean Section in the Setting of Intra-Amniotic Infection (#042)
Speaker:
Sally Kuehn (Duke University School of Medicine)
1:45 PM - 2:00 PM
Sex Differences in Cytokine Responses in Maternal Blood, Cord Blood, and Placenta after SARS-CoV-2 Infection in Pregnancy (#043)
Speaker:
Lin Li (University of California, San Francisco)
2:00 PM - 2:15 PM
Higher Syphilis Titers During Pregnancy are Associated with Worse Pregnancy and Infant Outcomes (#044)
Speaker:
Ryan Duggal (CDC Foundation)
2:15 PM - 2:30 PM
Hypertensive disorders of pregnancy in an area with high malaria burden (#045)
Speaker:
Nida Ozarslan (UCSF)
7:00 PM - 11:00 PM
Awards Ceremony/Dinner Dance
Saturday, July 19, 2025
7:30 AM - 8:30 AM
Annual Business Meeting
8:30 AM - 9:30 AM
General Session 3
9:30 AM - 10:30 AM
Stump the Professors
10:30 AM - 11:30 AM
Oral Abstract Session 5
10:30 AM - 10:45 AM
Descriptive Study of Congenital Syphilis: Identifying Gaps in Prevention (#046)
Speaker:
Katherine Lakey (Texas Tech University Health Sciences Center, School of Medicine)
10:45 AM - 11:00 AM
Recurrent Urinary Tract Infections and Long-Term Antibiotic Use During Pregnancy in Publicly and Commercially Insured US Populations (#047)
Speaker:
Yanmin Zhu (Brigham and Women's Hospital and Harvard Medical School)
11:00 AM - 11:15 AM
Prevalence and Treatment Adequacy of Syphilis in Pregnant Patients with Substance Use Disorders (#048)
Speaker:
Daryl Jayda Hart (University of South Carolina School of Medicine Greenville)
11:15 AM - 11:30 AM
Hepatitis C in Appalachia: A Cohort Study of Obstetric and Neonatal Outcomes (#049)
Speaker:
Rebecca Purvis (University of Tennessee Medical Center- Knoxville)
11:30 AM - 11:45 AM
Break
11:45 AM - 12:45 PM
Oral Abstract Session 6
11:45 AM - 12:00 PM
Stamping Out Trichomoniasis in Asymptomatic Women and iMplementing Practice Guidelines (#050)
Speaker:
Nkechinyelum Ogu (Northwestern University Feinberg School of Medicine)
12:00 PM - 12:15 PM
Randomized Study of Xpert Xpress MVP at the Point of Care versus Usual Care for Accurate Diagnosis and Appropriate Treatment of Vaginal Infections (#051)
Speaker:
Sharon Hillier (University of Pittsburgh)
12:15 PM - 12:30 PM
Sexual and Vaginal Health Priorities for Transgender Men: Perspectives from Patients in the Transgender Men’s Health, Experiences, and Responses to Testosterone (T-HEART) Study (#052)
Speaker:
Olivia Van Gerwen (University of Alabama at Birmingham)